cutaneal T - Cell Lymphoma is a cancer of T - cells of the skin and belong to the broad chemical group of disease of Non - Hodgkin ’s Lymphoma . It has two subtypes , Mycoid Fungoides and Sézary Syndrome . In Mycoid fungoides , the cancerous thyroxine - cells touch the skin . It progresses slowly and takes years to bring forward . While in Sézary syndrome , cancerous T - cells impress both the cutis and the peripheral blood . As compared to mycoid fungoides , sézary syndrome disseminate more rapidly .
What is Sézary Syndrome?
Sézary syndrome is a lymphoma of cutis - homing tetraiodothyronine - cell . Sézary syndrome is a more belligerent chassis of cutaneous MT - cell lymphoma . It can occur Delaware - novo ( on its own ) or at clock time it is an evolved form of mycoid fungoides . Malignant T - cells are have it off as Sézary cell and are launch in the blood line , skin and lymph knob . It is characterized by the comportment of abnormally determine lens nucleus ring Cerebriform .
Sézary syndrome is named after its discoverer Dr. Albert Sézary . It is also called as Sézary Lymphoma and Sézary Erythroderma .
Symptoms of Sézary Syndrome
In patients affected with Sézary syndrome , the tegument all over the soundbox is cut across with red roseola , it is itchy , peeling and painful . It is due to the fact that the malignant T - cells ( sézary cells ) move from the blood to the skin and are find oneself in these efflorescence . In addition , there may be red spot , brass and tumor on the skin . affected role with sézary syndrome often show enlarged lymph guest .
The other common symptoms associated with this circumstance include :
These malignant T - cell move to other role or organs of the dead body such aslymph nodes , spleen , off-white marrowand liver to shape Cancer the Crab .
Stages of Sézary Syndrome
The treatment decisiveness is base on the microscope stage of Sézary syndrome . There are four independent stages each having its characteristic feature . Generally , initial stages show less symptoms and show good response to treatment . While ripe stages become aggressive and do not respond to intervention . The TNM classification for sézary syndrome is as follows :
Stages of the Sézary syndrome may also have a vitamin B factor in classification . The B factor is based on how many unnatural lymphocytes are found in the origin .
Epidemiology of Sézary Syndrome
Sézary syndrome is an rare type of Cancer the Crab . It is the second most common cutaneal T - cell lymphoma and accounts for 3 - 5 % of these cases . It occur in adult from the age of 50 - 60 years and progresses apace . It is more or less more common in men than cleaning woman . There is no report of syndicate history and of inheritance convention regarding this syndrome noticed as yet .
Prognosis & Survival Rate of Sézary Syndrome
Prognosis of sézary syndrome depends on stage and character of lesion . It is an aggressive form of cutaneal T - cell lymphoma , difficult to cure and often has poor medical prognosis . The 5 year survival pace is approximately 20 - 27 % . Once sézary syndrome is diagnose , the selection rate is not more than 2 - 4 long time . Although with modern remedial strategy , there is a slight improvement in the overall survival rate of these patient role . However , Sézary syndrome shows high charge per unit of recurrence . Hence , the treatment is mostly palliative ( pain relieving ) .
Causes of Sézary Syndrome
The exact cause of sézary syndrome is not known . The peripheral CD4 + T - lymphocyte is believed to be the cause . While in some casing the involvement of CD8+/CD4- has also been consider . Loss or addition of genetical cloth from chromosome 10 and 17 are also observe in the sézary cancerous cells .
Risk Factors of Sézary Syndrome
There is no known risk factor for this type of dermal T - cell lymphoma .
Diagnosis of Sézary Syndrome
The clinical diagnosing is execute as follows :
Treatment of Sézary Syndrome
The discourse option count on the phase of Sézary syndrome , the number of lesions and type of T - cubicle lymphocytes . The aim of the treatment is to kill the malignant lymphocytes . There are some stock treatment that are currently used ; while some are being tested in various clinical trials .
However , overall alterative management of sézary ’s syndrome is challenging .
The cause and underlie pathogenesis cutaneous T - cell lymphomas and sézary syndrome is not yet clean . There is an urgent need to investigate its underlying molecular mechanisms . Unrevealing the physical process of carcinogenesis will enable good insight of sézary syndrome and will allow for in exploitation of specific therapeutics to ameliorate the survival rate in these patient .
